Male Bone Density Decreases at a Steady Rate During Hormone-Suppressing Prostate Cancer Treatment

University of Pennsylvania Cancer Center
Ultima Vez Modificado: 16 de mayo del 1999

The same bone loss seen in women who aren't producing estrogen is now being seen soon after men suppress testosterone and androgen production during prostate cancer therapy.

These male hormones are known to stimulate the early growth of prostate cancer, so at the first signs of a rising PSA level -- a test that measures a protein produced by cancerous prostate tissue -- many men choose to undergo drug therapy to shut down hormone production. But research conducted by investigators at the University of Washington is the first to document the rate of loss of bone mineral density in such patients. Lead researcher Dr. Celestia Higano reports that in this study, seventeen men experienced significant bone loss after only nine months on drugs that blocked production of androgen and testosterone -- a rate comparable to that of post-menopausal women who are not on estrogen replacement therapy. The mean percentage change in bone density in the men was about 4 percent in the lumbar spine and 2 percent in the hip, compared to beginning baseline measurements. Some, but not all, of that bone density was regained during a period of six months off the drugs.

The study suggests that men who receive suppression therapy should be followed for loss of bone mineral density, and if there is significant loss, they should be treated in a manner similar to women with postmenopausal osteoporosis, according to Higano.

Blogs

Breaking news: Supreme Court votes to uphold Affordable Care Act Subsidies
by Christina Bach, MSW, LCSW, OSW-C
June 26, 2015

Related News

BMD Loss Occurs Early in Androgen Deprivation Therapy

Apr 12, 2012

Study finds loss evident in men treated with ADT for nonmetastatic, hormone-sensitive prostate cancer


Bone mineral density test followed by selective alendronate found to improve resource use

May 20, 2010

Bone mineral density test followed by selective alendronate found to improve resource use


Substantial decreases in overall U.S. cancer rates between 1990 and 2007

Jun 20, 2011

Substantial decreases in overall U.S. cancer rates between 1990 and 2007